<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/707BCF26-5537-4036-9238-0A47315A7E61"><gtr:id>707BCF26-5537-4036-9238-0A47315A7E61</gtr:id><gtr:firstName>Deborah</gtr:firstName><gtr:otherNames>JG</gtr:otherNames><gtr:surname>Mackay</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_15078"><gtr:id>BB0DD985-70E9-4D96-AC7A-02D8C2963A89</gtr:id><gtr:title>Maths, Engineering and Life Sciences: making connections for precision medicine</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_PC_15078</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>A multitude of biological and environmental factors interact to mediate human development,
health and disease. It follows that a number of data types are required to describe these factors;
one-dimensional viewpoints ? even omic datasets ? are one-dimensional oversimplifications of
extraordinarily complex multi-cellular systems. To power precision medicine, we must build a
multi-dimensional picture, by integrating data from multiple viewpoints from the single-cell level
upwards.
Our overarching aim is to develop a step change in research capability towards precision
medicine at the University of Southampton. We request funding for a microfluidic engineer, a
systems biologist, to promote collaboration between mathematical, computational, engineering,
biology and medical specialisms in a new interdisciplinary laboratory. We request equipment to
develop new quantal microfluidic processes to increase information depth and resolution down to
the single cell level, novel analytical methods will then model the complexity of human disease.
This investment will produce new technology and methods to capture unique cross-cutting
datasets in disease systems, and new multi-dimensional analytical strategies in molecular
systems biology. It will not only uncover the spatiotemporal architecture of development in single
cells and cell populations; it will promote an imaginative, systems-biological mind-set, and a
common vocabulary of research and enquiry in microfluidics, data science, and medical research
across rare, infectious, acquired and non-communicable disease. The lasting impact of this
investment will be new tools and concepts for human development and disease, and resultant
advances towards the personalised therapeutic and preventative strategies that are the vision of
precision medicine.</gtr:technicalSummary><gtr:fund><gtr:end>2018-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2016-03-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>500000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>4AE0AD9C-A78B-4350-B299-4276A2E78843</gtr:id><gtr:title>Antibody Tumor Targeting Is Enhanced by CD27 Agonists through Myeloid Recruitment.</gtr:title><gtr:parentPublicationTitle>Cancer cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7fa2209b2627a6cf0be5675cae46dd98"><gtr:id>7fa2209b2627a6cf0be5675cae46dd98</gtr:id><gtr:otherNames>Turaj AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1535-6108</gtr:issn><gtr:outcomeId>5a8d70ae83e9a7.20066053</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8A22111-9EBB-4799-BB90-00AC7D9B48CA</gtr:id><gtr:title>Stem Cell Differentiation as a Non-Markov Stochastic Process.</gtr:title><gtr:parentPublicationTitle>Cell systems</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/551016ae9d090ff03012338f09f4001c"><gtr:id>551016ae9d090ff03012338f09f4001c</gtr:id><gtr:otherNames>Stumpf PS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2405-4712</gtr:issn><gtr:outcomeId>5a8d70aec096f4.90860678</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6535E449-AFA7-4404-907A-7338D5D7213C</gtr:id><gtr:title>Langerhans Cells-Programmed by the Epidermis.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6700434ed3ae142735008af203a83c9f"><gtr:id>6700434ed3ae142735008af203a83c9f</gtr:id><gtr:otherNames>Clayton K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>5a8d719b70cb99.44203890</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_15078</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>